Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trajan Group HoldingsASX:TRJ 38 Market Cap is A$44.3 Mil as of Jul. 14, 2026. GuruFocus rates ASX:TRJ with a GF Score™ of 38/100 and a GF Value™ of A$1.11 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Trajan Group Holdings ranks worse than 70.32% on this metric.
Trajan Group Holdings's quarterly market cap
declined
from Dec. 2024 (A$172.2 Mil) to Jun. 2025 (A$109.0 Mil) and
declined
from Jun. 2025 (A$109.0 Mil) to Dec. 2025 (A$106.8 Mil).
Trajan Group Holdings's annual market cap
declined
from Jun. 2023 (A$275.3 Mil) to Jun. 2024 (A$156.0 Mil) and
declined
from Jun. 2024 (A$156.0 Mil) to Jun. 2025 (A$109.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Trajan Group Holdings's Enterprise Value for Today is A$89.7 Mil.
Trajan Group Holdings (ASX:TRJ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trajan Group Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Trajan Group Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Trajan Group Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trajan Group Holdings (ASX:TRJ) has a Market Cap of A$44.3 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Trajan Group Holdings and its competitors. According to the industry distribution chart, Trajan Group Holdings ranks #609 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 70.3%.
Is Trajan Group Holdings' Market Cap too high?
Trajan Group Holdings' current Market Cap is A$44.3 Mil. Based on the distribution chart, Trajan Group Holdings ranks #609 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Trajan Group Holdings has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Trajan Group Holdings ranks #609 out of 866 companies for Market Cap. This places Trajan Group Holdings in the lower half of its industry. The industry median Market Cap is 116.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.94, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Trajan Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current Market Cap is A$44.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Trajan Group Holdings (ASX:TRJ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.11, compared to a current price of A$0.29 — trading 73.9% below its estimated fair value. The current Market Cap is A$44.3 Mil. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Trajan Group Holdings (ASX:TRJ), the current Market Cap is A$44.3 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trajan Group Holdings (ASX:TRJ) Overvalued in 2026?
Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued.
The current stock price of A$0.29 is trading 73.9% below its estimated GF Value™ of A$1.11.
GuruFocus considers Trajan Group Holdings to be Possible Value Trap.
Key valuation signals for ASX:TRJ:
Market Cap: A$44.3 Mil
GF Value™: A$1.11 vs. price of A$0.29 (73.9% below fair value)
No single metric tells the full story. See the ASX:TRJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score
Get the complete analysis for ASX:TRJ
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:TRJ has been successfully added to your 
